Troutman Pepper Hamilton Sanders LLP advised Cagent Vascular Inc. on the deal. Cagent Vascular announced the investment of US$9 million by Sectoral Asset Management. Along with...
Sectoral Asset Management’s $9 Million Investment in Cagent Vascular
BioXcel Therapeutics’ $100 Million Public Offering
Troutman Pepper Hamilton Sanders LLP advised BioXcel LLC on the deal. BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, announced the pricing of an...
Inhibikase Therapeutics’ $45 Million Follow-On Public Offering
Troutman Pepper Hamilton Sanders LLP advised Inhibikase Therapeutics, Inc. on the deal. Inhibikase Therapeutics, Inc. (Nasdaq: IKT), a clinical-stage pharmaceutical company developing therapeutics to modify the...
S&M Brands v. Josh Stein
Troutman Pepper Hamilton Sanders LLP advised S&M Brands on the deal. S&M Brands has been represented by lawfirm Troutman Pepper in a suit for declaratory and injunctive relief...
S&M Brands v. Josh Stein
Troutman Pepper Hamilton Sanders LLP advised S&M Brands on the deal. S&M Brands has been represented by lawfirm Troutman Pepper in a suit for declaratory and injunctive relief...
REPAY’s Acquisition of BillingTree
Troutman Pepper Hamilton Sanders LLP advised Repay Holdings Corporation on the deal. Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY”), a leading provider of vertically-integrated payment solutions, announced it...
VIA’s $10M Series A Financing
Troutman Pepper Hamilton Sanders LLP advised VIA on the deal. VIA, a global leader in AI and privacy-preserving software for the energy industry, has raised $10...
GE Healthcare’s Acquisition of Zionexa
Stephenson Harwood, De Marcellus and Disser, Mercure Avocats, Troutman Pepper advised GE Healthcare on the transaction while Goodwin Procter LLP advised the shareholders of Zionexa. Zionexa,...
Pacira Biosciences’ $3M Investment in Spine BioPharma
Troutman Pepper Hamilton Sanders LLP advised Spine BioPharma, LLC on the deal. Spine BioPharma, LLC, a company committed to developing non-surgical, non-opiate therapies to treat degenerative...
Eli Lilly’s Victory In Pancreatic Cancer Cases
Troutman Pepper Hamilton Sanders LLP advised Eli Lilly on the deal. Drug maker Eli Lilly successfully obtained the dismissal in both federal and state court of all...
Payroc WorldAccess’ Acquisition of Retriever Merchant Solutions
Troutman Pepper Hamilton Sanders LLP advised Payroc WorldAccess, LLC on the deal. Payroc WorldAccess, LLC (“Payroc”), a leading merchant acquirer and global payment processing organization, announced that...
Greenwood’s $40 Million Series A Financing
Troutman Pepper Hamilton Sanders LLP advised Greenwood on the deal, while Davis Polk advised Truist Ventures. Greenwood, the modern digital banking platform for Black and Latino...